Company record
GE Healthcare Ireland Limited
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about GE Healthcare Ireland Limited.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Apr 15 | Class II | GE Healthcare Ireland Limited Drug |
GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91. Presence of particulate matter FDA notice D-0448-2026 |
| Apr 15 | Class II | GE Healthcare Ireland Limited Drug |
GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63. Presence of particulate matter FDA notice D-0447-2026 |